Ginkgo Bioworks Holdings, Inc. (DNA)
11.25
+1.23
(+12.28%)
USD |
NYSE |
Oct 27, 15:59
Ginkgo Bioworks Holdings Enterprise Value : 707.36M for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 707.36M |
| October 23, 2026 | 705.54M |
| October 22, 2026 | 688.54M |
| October 21, 2026 | 706.75M |
| October 20, 2026 | 697.65M |
| October 19, 2026 | 710.40M |
| October 16, 2026 | 722.54M |
| October 15, 2026 | 813.00M |
| October 14, 2026 | 799.03M |
| October 13, 2026 | 813.00M |
| October 12, 2026 | 814.82M |
| October 09, 2026 | 888.28M |
| October 08, 2026 | 787.50M |
| October 07, 2026 | 795.39M |
| October 06, 2026 | 852.46M |
| October 05, 2026 | 1.008B |
| October 02, 2026 | 848.82M |
| October 01, 2026 | 857.92M |
| September 30, 2026 | 877.96M |
| September 29, 2026 | 825.14M |
| September 28, 2026 | 734.07M |
| September 25, 2026 | 746.22M |
| September 24, 2026 | 721.32M |
| September 23, 2026 | 619.94M |
| September 22, 2026 | 667.90M |
| Date | Value |
|---|---|
| September 21, 2026 | 583.51M |
| September 18, 2026 | 577.44M |
| September 17, 2026 | 575.01M |
| September 16, 2026 | 527.66M |
| September 15, 2026 | 523.41M |
| September 14, 2026 | 524.62M |
| September 11, 2026 | 508.83M |
| September 10, 2026 | 510.66M |
| September 09, 2026 | 511.26M |
| September 08, 2026 | 520.37M |
| September 04, 2026 | 520.98M |
| September 03, 2026 | 520.98M |
| September 02, 2026 | 525.83M |
| September 01, 2026 | 519.76M |
| August 31, 2026 | 512.48M |
| August 28, 2026 | 521.58M |
| August 27, 2026 | 539.80M |
| August 26, 2026 | 537.98M |
| August 25, 2026 | 556.80M |
| August 24, 2026 | 510.66M |
| August 21, 2026 | 548.30M |
| August 20, 2026 | 521.58M |
| August 19, 2026 | 567.12M |
| August 18, 2026 | 495.48M |
| August 17, 2026 | 519.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sotera Health Co. | 7.159B |
| CareDx, Inc. | 3.203B |
| Exagen, Inc. | 183.79M |
| BillionToOne, Inc. | 4.815B |
| Quest Diagnostics, Inc. | 32.61B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -57.32M |
| Revenue (Quarterly) | 20.16M |
| Total Expenses (Quarterly) | 77.48M |
| EPS Diluted (Quarterly) | -1.147 |
| Gross Profit Margin (Quarterly) | 30.37% |
| Profit Margin (Quarterly) | -284.4% |
| Earnings Yield | -48.36% |
| Normalized Earnings Yield | -48.35 |